130 related articles for article (PubMed ID: 2136995)
21. Nucleotide interactions with 5-HT1A binding sites directly labeled by [3H]-8-hydroxy-2-(DI-n-propylamino)tetralin ([3H]-8-OH-DPAT).
Schlegel JR; Peroutka SJ
Biochem Pharmacol; 1986 Jun; 35(12):1943-9. PubMed ID: 3013203
[TBL] [Abstract][Full Text] [Related]
22. Interactions of (+)- and (-)-8- and 7-hydroxy-2-(di-n-propylamino)tetralin at human (h)D3, hD2 and h serotonin1A receptors and their modulation of the activity of serotoninergic and dopaminergic neurones in rats.
Lejeune F; Newman-Tancredi A; Audinot V; Millan MJ
J Pharmacol Exp Ther; 1997 Mar; 280(3):1241-9. PubMed ID: 9067310
[TBL] [Abstract][Full Text] [Related]
23. Lack of apparent receptor reserve at postsynaptic 5-hydroxytryptamine1A receptors negatively coupled to adenylyl cyclase activity in rat hippocampal membranes.
Yocca FD; Iben L; Meller E
Mol Pharmacol; 1992 Jun; 41(6):1066-72. PubMed ID: 1352034
[TBL] [Abstract][Full Text] [Related]
24. Differential sensitivity of 3H-agonist binding to pre- and postsynaptic 5-HT1A receptors in bovine brain.
Iben LG; Mahle CD; Yocca FD
Br J Pharmacol; 1994 Dec; 113(4):1400-6. PubMed ID: 7889298
[TBL] [Abstract][Full Text] [Related]
25. Characterization of a novel serotonin receptor subtype (5-HT1S) in rat CNS: interaction with a GTP binding protein.
Zemlan FP; Schwab EF
J Neurochem; 1991 Dec; 57(6):2092-9. PubMed ID: 1834802
[TBL] [Abstract][Full Text] [Related]
26. Estrogen effects on 5-HT1A receptors in hippocampal membranes from ovariectomized rats: functional and binding studies.
Clarke WP; Maayani S
Brain Res; 1990 Jun; 518(1-2):287-91. PubMed ID: 2143962
[TBL] [Abstract][Full Text] [Related]
27. Irreversible blockade of central 5-HT1A receptor binding sites by the photoaffinity probe 8-methoxy-3'-NAP-amino-PAT.
Emerit MB; Gozlan H; Marquet A; Hamon M
Eur J Pharmacol; 1986 Aug; 127(1-2):67-81. PubMed ID: 2944752
[TBL] [Abstract][Full Text] [Related]
28. Mg2+ enhances high affinity [3H]8-hydroxy-2-(di-n-propylamino) tetralin binding and guanine nucleotide modulation of serotonin-1a receptors.
DeVinney R; Wang HH
J Recept Signal Transduct Res; 1995 Apr; 15(5):757-71. PubMed ID: 8747885
[TBL] [Abstract][Full Text] [Related]
29. Enrichment of saturated fatty acid containing phospholipids in sheep brain serotonin receptor preparations: use of microwave irradiation for rapid transesterification of phospholipids.
Banerjee P; Dawson G; Dasgupta A
Biochim Biophys Acta; 1992 Sep; 1110(1):65-74. PubMed ID: 1390837
[TBL] [Abstract][Full Text] [Related]
30. 2-(Alkylamino)tetralin derivatives: interaction with 5-HT1A serotonin binding sites.
Naiman N; Lyon RA; Bullock AE; Rydelek LT; Titeler M; Glennon RA
J Med Chem; 1989 Jan; 32(1):253-6. PubMed ID: 2521252
[TBL] [Abstract][Full Text] [Related]
31. Physicochemical properties of serotonin 5-HT3 binding sites solubilized from membranes of NG 108-15 neuroblastoma-glioma cells.
Miquel MC; Emerit MB; Bolaños FJ; Schechter LE; Gozlan H; Hamon M
J Neurochem; 1990 Nov; 55(5):1526-36. PubMed ID: 2213008
[TBL] [Abstract][Full Text] [Related]
32. Asymmetric extraction of membrane lipids by CHAPS.
Banerjee P; Buse JT; Dawson G
Biochim Biophys Acta; 1990 Jun; 1044(3):305-14. PubMed ID: 2142003
[TBL] [Abstract][Full Text] [Related]
33. Synthesis of (R,S)-trans-8-hydroxy-2-[N-n-propyl-N-(3'-iodo-2'-propenyl)amino]tetral in (trans-8-OH-PIPAT): a new 5-HT1A receptor ligand.
Zhuang ZP; Kung MP; Kung HF
J Med Chem; 1993 Oct; 36(21):3161-5. PubMed ID: 8230102
[TBL] [Abstract][Full Text] [Related]
34. Detection of the 5-HT1A receptor and 5-HT1A receptor mRNA in the rat bowel and pancreas: comparison with 5-HT1P receptors.
Kirchgessner AL; Liu MT; Howard MJ; Gershon MD
J Comp Neurol; 1993 Jan; 327(2):233-50. PubMed ID: 8425944
[TBL] [Abstract][Full Text] [Related]
35. Solubilization of serotonin1a and serotonin1b binding sites from bovine brain.
Asarch KB; Shih JC
J Neurochem; 1987 May; 48(5):1494-501. PubMed ID: 2951498
[TBL] [Abstract][Full Text] [Related]
36. Potency of 5-hydroxytryptamine1a agonists to inhibit adenylyl cyclase activity is a function of affinity for the "low-affinity" state of [3H]8-hydroxy-N,N-dipropylaminotetralin ([3H]8-OH-DPAT) binding.
Chamberlain J; Offord SJ; Wolfe BB; Tyau LS; Wang HL; Frazer A
J Pharmacol Exp Ther; 1993 Aug; 266(2):618-25. PubMed ID: 8355195
[TBL] [Abstract][Full Text] [Related]
37. Fentanyl and sufentanil inhibit agonist binding to 5-HT1A receptors in membranes from the rat brain.
Martin DC; Introna RP; Aronstam RS
Neuropharmacology; 1991 Apr; 30(4):323-7. PubMed ID: 1830134
[TBL] [Abstract][Full Text] [Related]
38. Heterogeneity of solubilized muscarinic cholinergic receptors: binding and hydrodynamic properties.
Baron B; Gavish M; Sokolovsky M
Arch Biochem Biophys; 1985 Jul; 240(1):281-96. PubMed ID: 4015105
[TBL] [Abstract][Full Text] [Related]
39. Intrinsic activity of enantiomers of 8-hydroxy-2-(di-n-propylamino)tetralin and its analogs at 5-hydroxytryptamine1A receptors that are negatively coupled to adenylate cyclase.
Cornfield LJ; Lambert G; Arvidsson LE; Mellin C; Vallgårda J; Hacksell U; Nelson DL
Mol Pharmacol; 1991 Jun; 39(6):780-7. PubMed ID: 1828859
[TBL] [Abstract][Full Text] [Related]
40. [3H]WB4101 labels the 5-HT1A serotonin receptor subtype in rat brain. Guanine nucleotide and divalent cation sensitivity.
Norman AB; Battaglia G; Creese I
Mol Pharmacol; 1985 Dec; 28(6):487-94. PubMed ID: 2867462
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
